1-20 of 42
Theresa L. Whiteside
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO-095: TGF-β carrying exosomes in plasma of HNSCC as potential biomarkers of disease progression in patients with HNSCC

Nils Ludwig, Saigopalakrishna S. Yerneni, Theresa L. Whiteside
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (18_Supplement): PO-095.
https://doi.org/10.1158/1557-3265.AACRAHNS23-PO-095
Published: 15 September 2023
View article titled, Abstract PO-095: TGF-β carrying exosomes in plasma of HNSCC as potential biomarkers of disease progression in patients with HNSCC
Journal Articles

Abstract PO-096: Cytokines in the lumen of exosomes are undetectable by immunoassays distorting cytokine profiles in HNC patients and healthy donors

Chang-Sook Hong, Brenda Diergaarde, Theresa L. Whiteside
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (18_Supplement): PO-096.
https://doi.org/10.1158/1557-3265.AACRAHNS23-PO-096
Published: 15 September 2023
View article titled, Abstract PO-096: Cytokines in the lumen of exosomes are undetectable by immunoassays distorting cytokine profiles in HNC patients and healthy donors
Journal Articles

Abstract B34: TGF-β-rich tumor-derived exosomes promote a proangiogenic phenotype in HNSCC

Nils Ludwig, Saigopalakrishna S. Yerneni, Juliana H. Azambuja, Beatrice M. Razzo, Cynthia S. Hinck, Monika Pietrowska, Andrew Hinck, Theresa L. Whiteside
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12_Supplement_2): B34.
https://doi.org/10.1158/1557-3265.AACRAHNS19-B34
Published: 15 June 2020
View article titled, Abstract B34: TGF-β-rich tumor-derived exosomes promote a proangiogenic phenotype in HNSCC
Journal Articles

Introducing a New Series: Immunotherapy Facts and Hopes

Ignacio Melero, Mario Sznol, Marlowe S. Tessmer, Theresa L. Whiteside, Jedd D. Wolchok
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (8): 1773–1774.
https://doi.org/10.1158/1078-0432.CCR-18-0408
Published: 12 April 2018
View article titled, Introducing a New Series: Immunotherapy Facts and Hopes
Open the PDF for Introducing a New Series: Immunotherapy Facts and Hopes in another window
Journal Articles

Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients

Marie-Nicole Theodoraki, Saigopalakrishna S. Yerneni, Thomas K. Hoffmann, William E. Gooding, Theresa L. Whiteside
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (4): 896–905.
https://doi.org/10.1158/1078-0432.CCR-17-2664
Published: 14 February 2018
View article titled, Clinical Significance of PD-L1<sup>+</sup> Exosomes in Plasma of Head and Neck Cancer Patients
Open the PDF for Clinical Significance of PD-L1<sup>+</sup> Exosomes in Plasma of Head and Neck Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Head and Neck Carcinoma Immunotherapy: Facts and Hopes

Theresa L. Whiteside
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (1): 6–13.
https://doi.org/10.1158/1078-0432.CCR-17-1261
Published: 02 January 2018
View article titled, Head and Neck Carcinoma Immunotherapy: Facts and Hopes
Open the PDF for Head and Neck Carcinoma Immunotherapy: Facts and Hopes in another window
Journal Articles

Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)

Lisa H. Butterfield, Fengmin Zhao, Sandra Lee, Ahmad A. Tarhini, Kim A. Margolin, Richard L. White, Michael B. Atkins, Gary I. Cohen, Theresa L. Whiteside, John M. Kirkwood, David H. Lawson
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (17): 5034–5043.
https://doi.org/10.1158/1078-0432.CCR-16-3016
Published: 31 August 2017
View article titled, Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)
Open the PDF for Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697) in another window
Includes: Supplementary data
Journal Articles

Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer

Sonja Ludwig, Theofanis Floros, Marie-Nicole Theodoraki, Chang-Sook Hong, Edwin K. Jackson, Stephan Lang, Theresa L. Whiteside
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (16): 4843–4854.
https://doi.org/10.1158/1078-0432.CCR-16-2819
Published: 14 August 2017
View article titled, Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer
Open the PDF for Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Emerging Opportunities and Challenges in Cancer Immunotherapy

Theresa L. Whiteside, Sandra Demaria, Maria E. Rodriguez-Ruiz, Hassane M. Zarour, Ignacio Melero
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (8): 1845–1855.
https://doi.org/10.1158/1078-0432.CCR-16-0049
Published: 14 April 2016
View article titled, Emerging Opportunities and Challenges in Cancer Immunotherapy
Open the PDF for Emerging Opportunities and Challenges in Cancer Immunotherapy in another window
Journal Articles

Abstract A79: The adenosine pathway in ovarian carcinoma: Tumor cells and tumor-derived exosomes express CD39 and CD73 ectonucleotidases, produce adenosine and mediate immune suppression

Marta E. Szajnik-Szczepanski, Magdalena Derbis, Michal Lach, Paulina Patalas, Marcin Michalak, Hanna Drzewiecka, Marta Glura, Ewa Nowak-Markwitz, Marek Spaczynski, Theresa L. Whiteside
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A79.
https://doi.org/10.1158/1078-0432.OVCA13-A79
Published: 13 May 2014
View article titled, Abstract A79: The adenosine pathway in ovarian carcinoma: Tumor cells and tumor-derived exosomes express CD39 and CD73 ectonucleotidases, produce adenosine and mediate immune suppression
Journal Articles

Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer

Patrick J. Schuler, Malgorzata Harasymczuk, Carmen Visus, Albert DeLeo, Sumita Trivedi, Yu Lei, Athanassios Argiris, William Gooding, Lisa H. Butterfield, Theresa L. Whiteside, Robert L. Ferris
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2433–2444.
https://doi.org/10.1158/1078-0432.CCR-13-2617
Published: 30 April 2014
View article titled, Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
Open the PDF for Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Effects of Adjuvant Chemoradiotherapy on the Frequency and Function of Regulatory T Cells in Patients with Head and Neck Cancer

Patrick J. Schuler, Malgorzata Harasymczuk, Bastian Schilling, Zenichiro Saze, Laura Strauss, Stephan Lang, Jonas T. Johnson, Theresa L. Whiteside
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (23): 6585–6596.
https://doi.org/10.1158/1078-0432.CCR-13-0900
Published: 01 December 2013
View article titled, Effects of Adjuvant Chemoradiotherapy on the Frequency and Function of Regulatory T Cells in Patients with Head and Neck Cancer
Open the PDF for Effects of Adjuvant Chemoradiotherapy on the Frequency and Function of Regulatory T Cells in Patients with Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)

Craig L. Slingluff, Jr, Sandra Lee, Fengmin Zhao, Kimberly A. Chianese-Bullock, Walter C. Olson, Lisa H. Butterfield, Theresa L. Whiteside, Philip D. Leming, John M. Kirkwood
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (15): 4228–4238.
https://doi.org/10.1158/1078-0432.CCR-13-0002
Published: 31 July 2013
View article titled, A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)
Open the PDF for A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602) in another window
Includes: Supplementary data
Journal Articles

The Immune Signature of CD8+CCR7+ T Cells in the Peripheral Circulation Associates with Disease Recurrence in Patients with HNSCC

Malgorzata Czystowska, William Gooding, Miroslaw J. Szczepanski, Andres Lopez-Abaitero, Robert L. Ferris, Jonas T. Johnson, Theresa L. Whiteside
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (4): 889–899.
https://doi.org/10.1158/1078-0432.CCR-12-2191
Published: 14 February 2013
View article titled, The Immune Signature of CD8<sup>+</sup>CCR7<sup>+</sup> T Cells in the Peripheral Circulation Associates with Disease Recurrence in Patients with HNSCC
Open the PDF for The Immune Signature of CD8<sup>+</sup>CCR7<sup>+</sup> T Cells in the Peripheral Circulation Associates with Disease Recurrence in Patients with HNSCC in another window
Includes: Supplementary data
Journal Articles

IGKC and Prognosis in Breast Cancer–Response

Theresa L. Whiteside, Soldano Ferrone
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (1): 305.
https://doi.org/10.1158/1078-0432.CCR-12-3200
Published: 02 January 2013
View article titled, IGKC and Prognosis in Breast Cancer–Response
Open the PDF for IGKC and Prognosis in Breast Cancer–Response in another window
Journal Articles

For Breast Cancer Prognosis, Immunoglobulin Kappa Chain Surfaces to the Top

Theresa L. Whiteside, Soldano Ferrone
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (9): 2417–2419.
https://doi.org/10.1158/1078-0432.CCR-12-0566
Published: 30 April 2012
View article titled, For Breast Cancer Prognosis, Immunoglobulin Kappa Chain Surfaces to the Top
Open the PDF for For Breast Cancer Prognosis, Immunoglobulin Kappa Chain Surfaces to the Top in another window
Includes: Supplementary data
Journal Articles

Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells

Carmen Visus, Yangyang Wang, Antonio Lozano-Leon, Robert L. Ferris, Susan Silver, Miroslaw J. Szczepanski, Randall E. Brand, Cristina R. Ferrone, Theresa L. Whiteside, Soldano Ferrone, Albert B. DeLeo, Xinhui Wang
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (19): 6174–6184.
https://doi.org/10.1158/1078-0432.CCR-11-1111
Published: 02 October 2011
View article titled, Targeting ALDH<sup>bright</sup> Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8<sup>+</sup> T Cells
Open the PDF for Targeting ALDH<sup>bright</sup> Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8<sup>+</sup> T Cells in another window
Includes: Supplementary data
Journal Articles

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

Lisa H. Butterfield, A. Karolina Palucka, Cedrik M. Britten, Madhav V. Dhodapkar, Leif Håkansson, Sylvia Janetzki, Yutaka Kawakami, Thomas-Oliver Kleen, Peter P. Lee, Cristina Maccalli, Holden T. Maecker, Vernon C. Maino, Michele Maio, Anatoli Malyguine, Giuseppe Masucci, Graham Pawelec, Douglas M. Potter, Licia Rivoltini, Lupe G. Salazar, Dolores J. Schendel, Craig L. Slingluff, Jr, Wenru Song, David F. Stroncek, Hideaki Tahara, Magdalena Thurin, Giorgio Trinchieri, Sjoerd H. van Der Burg, Theresa L. Whiteside, Jon M. Wigginton, Francesco Marincola, Samir Khleif, Bernard A. Fox, Mary L. Disis
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (10): 3064–3076.
https://doi.org/10.1158/1078-0432.CCR-10-2234
Published: 15 May 2011
View article titled, Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
Open the PDF for Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers in another window
Journal Articles

Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer

Magis Mandapathil, Miroslaw J. Szczepanski, Marta Szajnik, Jin Ren, Diana E. Lenzner, Edwin K. Jackson, Elieser Gorelik, Stephan Lang, Jonas T. Johnson, Theresa L. Whiteside
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (20): 6348–6357.
https://doi.org/10.1158/1078-0432.CCR-09-1143
Published: 14 October 2009
View article titled, Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer
Open the PDF for Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia

Miroslaw J. Szczepanski, Marta Szajnik, Malgorzata Czystowska, Magis Mandapathil, Laura Strauss, Ann Welsh, Kenneth A. Foon, Theresa L. Whiteside, Michael Boyiadzis
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3325–3332.
https://doi.org/10.1158/1078-0432.CCR-08-3010
Published: 18 May 2009
View article titled, Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
Open the PDF for Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia in another window